SunLink Health Systems Inc. (SSY) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
900 CIRCLE 75 PARKWAY ATLANTA, GA 30339 |
| State of Incorp. | OH |
| Fiscal Year End | June 30 |
| Industry (SIC) | 8062 - General Medical and Surgical Hospitals (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2025 Q3 | 12/31/2024 Q2 | 9/30/2024 Q1 | 6/30/2024 Q4 | 3/31/2024 Q3 | 12/31/2023 Q2 | 9/30/2023 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 8,020 | 7,529 | 7,170 | 1,211 | 2,055 | 2,820 | |||
| Cash and cash equivalent | 8,020 | 7,529 | 7,170 | 1,211 | 2,055 | 2,820 | |||
| Receivables | 2,831 | 3,011 | 3,371 | 3,078 | 3,061 | 2,764 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,554 | 1,547 | 1,553 | 1,561 | 1,593 | 1,602 | |||
| Inventory | 1,554 | 1,547 | 1,553 | 1,561 | 1,593 | 1,602 | |||
| Asset, held-for-sale, not part of disposal group | 256 | 1,915 | 1,959 | 3,512 | 5,328 | 7,284 | |||
| Other undisclosed current assets | 1,545 | 1,614 | 1,611 | 1,604 | 1,673 | 2,061 | |||
| Total current assets: | 14,206 | 15,616 | 15,664 | 10,966 | 13,710 | 16,531 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 389 | 473 | 516 | 592 | 649 | 732 | |||
| Property, plant and equipment | 2,053 | 2,316 | 2,809 | 2,903 | 2,921 | 2,891 | |||
| Intangible assets, net (including goodwill) | 1,180 | 1,180 | 1,180 | 1,180 | 1,180 | 1,180 | |||
| Intangible assets, net (excluding goodwill) | 1,180 | 1,180 | 1,180 | 1,180 | 1,180 | 1,180 | |||
| Other noncurrent assets | 44 | 44 | 443 | 503 | 327 | 389 | |||
| Total noncurrent assets: | 3,666 | 4,013 | 4,948 | 5,178 | 5,077 | 5,192 | |||
| TOTAL ASSETS: | 17,872 | 19,629 | 20,612 | 16,144 | 18,787 | 21,723 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,137 | 2,689 | 2,860 | 2,389 | 2,344 | 2,212 | |||
| Accounts payable | 1,151 | 1,338 | 1,905 | 1,532 | 1,420 | 1,359 | |||
| Accrued liabilities | 986 | 1,351 | 955 | 857 | 924 | 853 | |||
| Debt | 320 | 339 | 331 | 3 | |||||
| Other liabilities | 932 | 823 | 1,022 | 675 | 714 | 991 | |||
| Other undisclosed current liabilities | 106 | 895 | 2,170 | 1,787 | |||||
| Total current liabilities: | 3,495 | 3,851 | 4,213 | 3,959 | 5,228 | 4,993 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 79 | 197 | |||||||
| Finance lease, liability | 79 | 197 | |||||||
| Liabilities, other than long-term debt | 201 | 215 | 377 | 346 | 450 | 525 | |||
| Other liabilities | 122 | 69 | 180 | 73 | 118 | 113 | |||
| Operating lease, liability | 79 | 146 | 197 | 273 | 332 | 412 | |||
| Other undisclosed noncurrent liabilities | 16 | 139 | (148) | 231 | 105 | 126 | |||
| Total noncurrent liabilities: | 296 | 354 | 426 | 577 | 555 | 651 | |||
| Total liabilities: | 3,791 | 4,205 | 4,639 | 4,536 | 5,783 | 5,644 | |||
| Equity | |||||||||
| Equity, attributable to parent | 14,081 | 15,424 | 15,973 | 11,608 | 13,004 | 16,079 | |||
| Common stock | 3,521 | 3,521 | 3,521 | 3,521 | 3,521 | 3,521 | |||
| Additional paid in capital | 10,747 | 10,747 | 10,747 | 10,747 | 10,747 | 10,747 | |||
| Accumulated other comprehensive income | 227 | 227 | 227 | 150 | 150 | 150 | |||
| Retained earnings (accumulated deficit) | (414) | 929 | 1,478 | (2,810) | (1,414) | 1,661 | |||
| Total equity: | 14,081 | 15,424 | 15,973 | 11,608 | 13,004 | 16,079 | |||
| TOTAL LIABILITIES AND EQUITY: | 17,872 | 19,629 | 20,612 | 16,144 | 18,787 | 21,723 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2025 Q3 | 12/31/2024 Q2 | 9/30/2024 Q1 | 6/30/2024 Q4 | 3/31/2024 Q3 | 12/31/2023 Q2 | 9/30/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 7,935 | 7,923 | 7,913 | 7,462 | 8,510 | 8,555 | ||
| Other undisclosed gross profit | (18,253) | |||||||
| Gross profit: | 7,935 | 7,923 | (10,340) | 7,462 | 8,510 | 8,555 | ||
| Operating expenses | (1,290) | (1,245) | (1,282) | (1,059) | (1,233) | (1,331) | ||
| Other undisclosed operating income (loss) | (7,657) | (7,872) | 10,947 | (7,256) | (7,710) | (7,674) | ||
| Operating loss: | (1,012) | (1,194) | (675) | (853) | (433) | (450) | ||
| Loss from continuing operations before equity method investments, income taxes: | (1,012) | (1,194) | (675) | (853) | (433) | (450) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (58) | 752 | 23 | 19 | 29 | 24 | ||
| Loss from continuing operations before income taxes: | (1,070) | (442) | (652) | (834) | (404) | (426) | ||
| Income tax expense (benefit) | 10 | (3) | (2) | |||||
| Loss from continuing operations: | (1,070) | (442) | (652) | (824) | (407) | (428) | ||
| Other undisclosed net income | 784 | |||||||
| Net income (loss): | (1,070) | (442) | 132 | (824) | (407) | (428) | ||
| Other undisclosed net income (loss) attributable to parent | (273) | (107) | 4,156 | (572) | (2,668) | (916) | ||
| Net income (loss) available to common stockholders, diluted: | (1,343) | (549) | 4,288 | (1,396) | (3,075) | (1,344) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2025 Q3 | 12/31/2024 Q2 | 9/30/2024 Q1 | 6/30/2024 Q4 | 3/31/2024 Q3 | 12/31/2023 Q2 | 9/30/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (1,070) | (442) | 132 | (824) | (407) | (428) | ||
| Comprehensive income (loss): | (1,070) | (442) | 132 | (824) | (407) | (428) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (273) | (107) | 4,233 | (572) | (2,668) | (916) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (1,343) | (549) | 4,365 | (1,396) | (3,075) | (1,344) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.